Rifaximin SSD in Dementia Trial

Clinical trial NCT06718686 · RECRUITING

Trial details

NCT number: NCT06718686
Sponsor: Jasmohan Bajaj
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Dementia Alzheimer Type Dementia Associated With Cerebrovascular Disease

Start date: 2024-12-30
Primary completion: 2027-10-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.